Jarislowsky, Fraser Ltd’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$666K Sell
6,995
-22
-0.3% -$2.02K ﹤0.01% 152
2025
Q2
$612K Sell
7,017
-506
-7% -$42.9K ﹤0.01% 154
2025
Q1
$676K Sell
7,523
-400
-5% -$35.8K ﹤0.01% 149
2024
Q4
$633K Hold
7,923
﹤0.01% 151
2024
Q3
$713K Sell
7,923
-632
-7% -$53.2K ﹤0.01% 149
2024
Q2
$673K Sell
8,555
-464
-5% -$38K ﹤0.01% 149
2024
Q1
$786K Sell
9,019
-8,548
-49% -$730K ﹤0.01% 153
2023
Q4
$1.45M Buy
17,567
+7,788
+80% +$594K 0.01% 142
2023
Q3
$766K Sell
9,779
-1,475
-13% -$123K 0.01% 152
2023
Q2
$991K Sell
11,254
-26
-0.2% -$2.24K 0.01% 148
2023
Q1
$909K Sell
11,280
-626
-5% -$51K 0.01% 150
2022
Q4
$925K Sell
11,906
-1,150
-9% -$93.2K 0.01% 154
2022
Q3
$1.05M Sell
13,056
-250
-2% -$22.5K 0.01% 149
2022
Q2
$1.19M Sell
13,306
-530
-4% -$53.7K 0.01% 148
2022
Q1
$1.53M Sell
13,836
-650
-4% -$68.7K 0.01% 144
2021
Q4
$1.5M Sell
14,486
-193
-1% -$22.3K 0.01% 149
2021
Q3
$1.84M Sell
14,679
-133
-0.9% -$17.2K 0.01% 149
2021
Q2
$1.84M Buy
14,812
+53
+0.4% +$6.66K 0.01% 150
2021
Q1
$1.74M Sell
14,759
-13,557
-48% -$1.59M 0.01% 148
2020
Q4
$3.32M Buy
28,316
+1,587
+6% +$175K 0.02% 126
2020
Q3
$2.78M Sell
26,729
-4,221
-14% -$424K 0.02% 127
2020
Q2
$2.84M Sell
30,950
-4,608
-13% -$442K 0.02% 128
2020
Q1
$3.21M Sell
35,558
-1,015
-3% -$108K 0.02% 119
2019
Q4
$4.15M Sell
36,573
-2,743
-7% -$301K 0.02% 117
2019
Q3
$4.27M Buy
39,316
+210
+0.5% +$21.9K 0.02% 115
2019
Q2
$3.81M Sell
39,106
-308,428
-89% -$28.2M 0.02% 115
2019
Q1
$31.7M Sell
347,534
-28,638
-8% -$2.56M 0.2% 67
2018
Q4
$34.2M Sell
376,172
-6,128
-2% -$573K 0.24% 65
2018
Q3
$34.3M Buy
382,300
+6,123
+2% +$566K 0.21% 67
2018
Q2
$32.2M Sell
376,177
-4,038
-1% -$337K 0.19% 67
2018
Q1
$30.5M Sell
380,215
-5,596
-1% -$462K 0.19% 70
2017
Q4
$31.2M Sell
385,811
-20,492
-5% -$1.64M 0.18% 70
2017
Q3
$31.6M Buy
406,303
+7,118
+2% +$591K 0.19% 66
2017
Q2
$35.4M Sell
399,185
-12,709
-3% -$1.07M 0.22% 68
2017
Q1
$33.2M Sell
411,894
-17,345
-4% -$1.35M 0.21% 71
2016
Q4
$30.6M Buy
429,239
+104,911
+32% +$8.24M 0.2% 73
2016
Q3
$28M Sell
324,328
-11,147
-3% -$971K 0.19% 73
2016
Q2
$29.1M Sell
335,475
-696
-0.2% -$56.3K 0.2% 67
2016
Q1
$25.2M Buy
336,171
+60,083
+22% +$4.53M 0.18% 78
2015
Q4
$21.2M Buy
276,088
+253,849
+1,141% +$19.1M 0.16% 81
2015
Q3
$1.49M Sell
22,239
-1,475
-6% -$109K 0.01% 124
2015
Q2
$1.76M Sell
23,714
-5,350
-18% -$409K 0.01% 122
2015
Q1
$2.27M Sell
29,064
-550
-2% -$41.7K 0.02% 123
2014
Q4
$2.14M Buy
29,614
+270
+0.9% +$18.8K 0.01% 121
2014
Q3
$1.82M Sell
29,344
-420
-1% -$26.7K 0.01% 118
2014
Q2
$1.9M Sell
29,764
-275
-0.9% -$16.7K 0.01% 114
2014
Q1
$1.85M Sell
30,039
-10,548
-26% -$614K 0.01% 117
2013
Q4
$2.33M Sell
40,587
-6,177
-13% -$350K 0.01% 113
2013
Q3
$2.49M Sell
46,764
-8,600
-16% -$463K 0.01% 113
2013
Q2
$2.85M Buy
+55,364
New +$2.74M 0.02% 109

Other funds holding MDT

Jarislowsky, Fraser Ltd's MDT Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd reduced its Medtronic (MDT) stake by 0.31% in Q3 2025, selling an estimated $2.02K and leaving 6,995 shares worth $666K. The position accounts for ﹤0.01% of the portfolio, ranked #152.

Jarislowsky, Fraser Ltd first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $35.4M in Q2 2017. 2,170 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Jarislowsky, Fraser Ltd held 6,995 shares of Medtronic worth $666K as of Q3 2025.
  • Jarislowsky, Fraser Ltd sold 22 Medtronic shares in Q3 2025, an estimated $2.02K.
  • Medtronic made up ﹤0.01% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #152 holding.
  • Jarislowsky, Fraser Ltd first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • Jarislowsky, Fraser Ltd's Medtronic position peaked at $35.4M in Q2 2017.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.